clinical trial · NCT07551713
Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects
Haisco Pharmaceutical Group Co., Ltd.·phase1·completed·n = 40
HealthyTested Lidocaine and Prilocaine CreamReference Lidocaine and Prilocaine Cream (EMLA®)
brief summary
The test formulation (Lidocaine and Prilocaine Cream, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (EMLA®, AstraZeneca) were applied to healthy adult subjects under fasting conditions to evaluate the bioequivalence and safety of the two formulations
started
Jun 11, 2020
primary completion
Jul 10, 2020
completion
Sep 28, 2020
last updated
Apr 27, 2026
official title
Bioequivalence and Safety Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects : A Randomized, Open-label, Single-dose, Two-period, Cross-over Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol